AITHENA Joins Reuters Pharma Customer Engagement Europe 2025
- Sakshi Meshram
- Mar 6
- 2 min read
28–29 October 2025 | London
AITHENA attended Reuters Pharma Customer Engagement Europe 2025 as Platinum Sponsor. The two-day summit in London brought together over 300 senior pharmaceutical executives and C-suite leaders from across Europe's top pharma companies, focused on driving customer engagement innovation and commercial excellence.
The company was represented by co-founders Dr. William McCully and Dr. Hank Du, Marketing Manager Sakshi Meshram, and Product and Operations interns Joy Wong and Adela Hoxha. AITHENA hosted a booth across both days of the conference, drawing interest from commercial leaders, medical affairs professionals, and digital innovation teams.
Dr. William McCully and Dr. Hank Du presented on how automated MLR review and AI-optimised processes can transform content activation speed and scale production from global to local markets. Dr. McCully put the challenge plainly to the audience: "I went on the top 10 pharmaceutical websites and looked at your product pages. 6 out of 10 of them said 'Down for maintenance or data coming soon.' This just isn't good enough."
The presentation addressed a persistent operational challenge facing pharmaceutical commercial teams — the gap between content production ambition and the reality of slow, manual approval pipelines. As organisations face increasing pressure to activate content faster across multiple markets, the MLR review process remains a critical bottleneck. MLRcle delivers comprehensive material reviews in minutes while maintaining full alignment with ABPI and EFPIA compliance standards.
The conference programme examined how leading organisations are rethinking customer engagement models, accelerating digital transformation, and building operational capabilities for an increasingly complex market. AITHENA's presence across both days of the summit reflects the company's commitment to being a central voice in these conversations. Broken content pipelines, lengthy approval cycles, and inconsistent review quality remain some of the biggest drains on commercial performance — and MLRcle was built by pharmaceutical industry insiders who have lived these challenges firsthand.
The insights shared by Dr. McCully and Dr. Hank Du at the summit have since been published on the Reuters Events website. Read the full article at the link below.
Comments